AI assistant
Sending…
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2022
Jun 29, 2022
32464_dirs_2022-06-29_3be4b523-3c45-4a72-9dab-9839ba40d217.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2022-06-27
Reporting Person: Skarpelos Athanasios (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-27 | Stock Option (Right to Buy) | $10.09 | A | 50000 | Acquired | 2032-06-27 | Common Stock (50000) | Direct |
More from ANAVEX LIFE SCIENCES CORP.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Feb 25
Interim / Quarterly Report
2026
Feb 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Annual Report
2025
Nov 25
Regulatory Filings
2025
Nov 25